Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer
Clinical trial NCT00482391 · COMPLETED
Trial details
- NCT number
- NCT00482391
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2011-07-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.